The Medispend Blog
Insights, best practices and industry trends to help life sciences teams stay compliant and ahead.
HCP Engagement Needs Assessment: How to Plan, Document, and Defend Compliant HCP Interactions
Engaging healthcare professionals (HCPs) is essential for life sciences companies seeking expert clinical insight, scientific guidance, and real-world perspectives. From advisory boards and speaker programs
HCP Engagement Needs Assessment: How to Plan, Document, and Defend Compliant HCP Interactions
Engaging healthcare professionals (HCPs) is essential for life sciences companies seeking expert clinical insight, scientific guidance, and real-world perspectives. From advisory boards and speaker programs
Why Coaching MSLs Matters: How the Right Approach Drives Better Scientific Engagement
Consider this fair warning, we’re about to say the one word that makes MSLs a little twitchy – sales. Coaching has long been recognized as
Reintroducing iContracts: Reimagining a Market Leading Revenue Management Platform
For years, iContracts set the standard for revenue management in life sciences. Today, we are proud to reintroduce the platform, strengthened through new investment, enhanced
Confidential Information (CI): A Board-Level Risk Hiding in Plain Sight
For life sciences executives, intellectual property risk is typically framed around patents, exclusivity periods, and litigation exposure. Yet an increasing risk to enterprise value sits
Are You Really Ready for a CMS Open Payments Audit?
CMS Open Payments audits are now a real and growing part of the transparency landscape, designed to confirm that reported data is accurate, complete, and
5 Survival Lessons from the Life Sciences Coaching Trenches
As coaches and managers, we spend a lot of time and energy making sure our employees are okay. We worry about how to give feedback
State Price Transparency Reporting Is Getting Riskier — Here’s What You Can Do
As global macroeconomic conditions worsen and funding slowdown continues, Indian startups are cutting their spends on an integral part of tech businesses.
Why Life Sciences Companies Are Choosing Integrated SaaS Platforms Over Point Solutions to Ensure Compliant Growth
As global macroeconomic conditions worsen and funding slowdown continues, Indian startups are cutting their spends on an integral part of tech businesses.